GB 40 Tablet contains Ginkgo Biloba extract standardized to 40 mg per tablet, widely utilized for its neuroprotective and vasoregulatory properties. Ginkgo Biloba is derived from the leaves of the Ginkgo biloba tree and is known to improve cerebral blood flow, enhance cognitive function, and exhibit antioxidant effects. This formulation is indicated for symptomatic treatment of cognitive disorders such as memory impairment, concentration difficulties, and age-related cognitive decline. Additionally, GB 40 Tablet may be beneficial in managing peripheral vascular diseases by promoting microcirculation and reducing symptoms like intermittent claudication. The active constituents, including flavonoids and terpenoids, contribute to the modulation of neurotransmitter activity and protection against oxidative neuronal damage. GB 40 Tablet is generally well tolerated; however, caution is advised in patients with bleeding disorders or those on anticoagulant therapy due to potential increased bleeding risk. It is recommended to use this medication under medical supervision, particularly in individuals with underlying cardiovascular conditions or concurrent medication use. Dosage and duration of therapy should be tailored according to clinical response and physician guidance. GB 40 Tablet offers a therapeutic option for enhancing cognitive health and vascular function in appropriate patient populations.